Three years after first acquiring the site in Mildura in Victoria, Australian medicinal cannabis company Cann Group has been given permission to cultivate the drug at the now-completed, high-tech facility.
The Office of Drug Control (ODC) has today granted Cann Group the necessary permit to allow commercial cultivation of medicinal cannabis to commence at its new digs in Mildura, which have been under constructions for quite some time, delayed by COVID-19 outbreaks and a reliance on imported expertise from European specialists.
The company, which was the first in Australia to receive medical cannabis production and research licenses, raised more than $60 million from investors alongside a $50 million loan from National Australia Bank to get the $130 million Mildura greenhouse over the line.
The Mildura facility has reached the practical completion stage, with just final fit-out and commissioning activity to still be finished in some areas. The first stage of the facility will deliver annual dry flower capacity of 12,500kg with plans to expand this to 50,000kg, making it the largest cannabinoid medicine production facility in Australia.